Covaxin: Clinical Trails Done on 375 Volunteers
Covaxin India's first indigenous COVID-19 vaccine, developed by Bharat biotech successful enters human trials BHARAT BIOTECH is pleased to announce it's three COVID-19 vaccines in collaboration with University of Wisconsin, ICMR and THOMAS JEFERSON UNIVERSITY. Bhart biotech is a pioneering biotechnology company known for its world class R&D and manufacturing capabilities. Press release from BHART BIOTECH June 29 India's 1st COVID-19 vaccine COVAXIN, developed by Bharat Biotech gets DCGI (Drug Controller General of India) approv Phase I & II Human clinical trials. Bharat Biotech's COVID-19 Vaccine Clinical Trials Done On 375 Volunteers: All You Need To Know In the race to develop a cure for coronavirus, India has taken first strides as human trial of Bharat Biotech's anti-COVID-19 vaccine Covaxin began across the country. “India’s First Indigenous COVID-19 Vaccine Covaxin initiated phase-1 clinical trials across the country on 15th July 2020. This is ...